OTCM
LQWC
Market cap532kUSD
Jul 09, Last price
0.01USD
1D
0.84%
1Q
-13.59%
Jan 2017
584.62%
IPO
867.39%
Name
LifeQuest World Corp
Chart & Performance
P/E
—
P/S
4.02
EPS
—
Div Yield, %
—
Shrs. gr., 5y
75.51%
Rev. gr., 5y
129.82%
Revenues
134k
-36.88%
Net income
-382k
L+123.83%
CFO
115k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
LifeQuest World Corporation, operating through its subsidiary entities, specializes in delivering comprehensive solutions for managing and treating both sewage and industrial effluents. The company engineers onsite wastewater treatment systems capable of purifying grey and black water, rendering it fit for reuse in applications like irrigation, toilet flushing, and cleaning. Furthermore, LifeQuest tackles the purification of industrial wastewater across diverse sectors such as textile, tannery, fisheries, dairy, and processed water industries. Among its key offerings is Biopipe, an advanced biological wastewater treatment system deployed in a broad range of settings, including private residences, commercial and multi-unit developments, hotels, hospitals, industrial complexes, and recreational areas. It also provides Abrimix, a water treatment technology versatile enough to process wastewater, processed water, and raw water sources. For water filtration needs, LifeQuest supplies Glanris, a non-toxic filtration media utilized by municipalities, businesses, and individual homeowners and consumers alike. The company also features Goslyn, a grease recovery device specifically engineered to efficiently remove fats, oils, and grease (FOG) from wastewater effluents. Founded in 1997, LifeQuest World Corporation maintains its headquarters in Ridgefield Park, New Jersey.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑05 | 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||